Pelvic congestion syndrome is an underdiagnosed cause of chronic pelvic pain (CPP) resulting from incompetent, dilated, and refluxing pelvic veins, estimated to account for up to 30% of CPP cases. [1] It predominantly affects premenopausal, multiparous women and is characterized by dull, aching pelvic pain worsened by prolonged standing, intercourse, and the premenstrual period. [1-3]
1. History
- Pain character: Dull, aching, unilateral or bilateral pelvic pain with occasional sharp flares [3]
- Timing/triggers: Worsened by prolonged standing, walking, fatigue; worse premenstrually; exacerbated by coitus [1][4]
- Pathognomonic feature: Prolonged postcoital ache (not just dyspareunia during intercourse) — this distinguishes PCS from other CPP causes [1][3]
- Associated symptoms: Dysmenorrhea, deep dyspareunia, pelvic heaviness, bladder irritability (dysuria, urinary frequency), rectal discomfort, vulvar/perineal varicosities [4-6]
- Relieving factors: Pain improves with lying down [3]
- Important negatives: Absence of fever, peritoneal signs, vaginal bleeding, or acute-onset pain argues against surgical emergencies
2. Alarm Features
- Acute-onset severe pelvic pain → rule out ovarian torsion, ruptured ectopic, ruptured ovarian cyst
- Fever + pelvic pain → rule out PID/tubo-ovarian abscess
- Unilateral leg swelling with pelvic pain → consider iliac vein thrombosis (May-Thurner syndrome) [7-8]
- Hematuria with pelvic pain → may suggest nutcracker syndrome (left renal vein compression) or urologic pathology [5]
- New-onset postmenopausal pelvic pain with venous dilation → consider malignancy causing venous obstruction
3. Medications
- Medical management:
- Medroxyprogesterone acetate (MPA) 30 mg/day — suppresses ovarian function; provides short-term relief [6][9]
- GnRH agonists (e.g., goserelin 3.6 mg/month) — superior to MPA in one RCT for venographic improvement and symptom relief at 1 year, but limited by side effects of hypoestrogenism [9]
- Micronized purified flavonoid fraction (MPFF) 1000 mg daily — venoactive drug shown to improve QoL and reduce symptom severity in a placebo-controlled trial [10]
- NSAIDs for symptomatic pain relief
- Cautions: Long-term GnRH agonist use requires add-back therapy; hormonal therapies have unproven long-term efficacy [6]
- Contraindicated: Estrogen-containing contraceptives may theoretically worsen venous dilation (estrogen promotes venous distensibility), though evidence is limited
4. Diet
- No specific dietary triggers are well-established for PCS
- General venous health recommendations: adequate hydration, high-fiber diet to avoid constipation (straining increases intra-abdominal pressure)
- Weight management — obesity increases venous hypertension
5. Review of Systems
- GYN: Dysmenorrhea, dyspareunia, postcoital ache, menstrual irregularity, vulvar varicosities
- Urologic: Dysuria, urinary frequency, hematuria (in absence of infection — strongly correlated with PCS) [5]
- GI: Rectal discomfort, bloating, constipation
- Vascular: Lower extremity varicose veins (especially atypical distribution — vulvar, perineal, buttock, posterior thigh) [6]
- Psych: Anxiety, depression — common comorbidities that worsen symptom burden [9][11]
6. Collateral History and Family History
- Parity: Multiparity is the strongest demographic risk factor [3-4]
- Family history: Genetic predisposition to venous insufficiency, varicose veins, or connective tissue disorders [2]
- Social context: Impact on sexual functioning, work productivity, and psychological well-being should be assessed [9]
7. Risk Factors
- Multiparity (most significant) [1][3]
- Premenopausal status (estrogen-dependent venous dilation) [1][5]
- History of varicose veins or chronic venous insufficiency [2]
- Prolonged standing occupations [4]
- Obesity [2]
- Anatomic variants: Nutcracker syndrome (left renal vein compression by SMA), May-Thurner syndrome (left common iliac vein compression by right common iliac artery) [7-8]
- Genetic predisposition, connective tissue abnormalities [2]
8. Differential Diagnosis
Significant clinical overlap exists between PCS and other causes of CPP: [1][11]
- Endometriosis — can coexist with PCS; dysmenorrhea and dyspareunia overlap, but endometriosis pain is often cyclical and associated with infertility [1]
- Adenomyosis — heavy menstrual bleeding, diffusely enlarged uterus
- Ovarian cysts/masses — acute or intermittent pain, identifiable on imaging
- Pelvic inflammatory disease — fever, cervical motion tenderness, purulent discharge
- Interstitial cystitis/bladder pain syndrome — suprapubic pain, urgency, frequency
- Irritable bowel syndrome — altered bowel habits, bloating
- Musculoskeletal/myofascial pelvic pain — present in 50–90% of CPP patients [12]
- Nutcracker syndrome — left flank pain, hematuria, left renal vein compression [7]
- May-Thurner syndrome — left leg swelling, iliac vein compression [7][13]
- Ovarian torsion (cannot-miss) — acute onset, nausea/vomiting
9. Past Medical History
- Prior pregnancies (number and mode of delivery)
- History of varicose veins or DVT
- Previous pelvic surgery (hysterectomy, oophorectomy, laparoscopy)
- Prior evaluation for CPP (laparoscopy negative in up to 50% of CPP cases — PCS is often missed at laparoscopy due to pneumoperitoneum compressing veins) [1]
- Endometriosis, fibroids, or other gynecologic conditions
- History of venous thromboembolism
10. Physical Exam
- Vital signs: Typically normal
- Abdominal exam: Tenderness over the ovarian point (junction of upper and middle thirds of a line from umbilicus to ASIS) — 94% sensitive and 77% specific for venous-origin pelvic pain when combined with postcoital ache [3]
- Pelvic exam: Bimanual examination reproducing focal adnexal tenderness; cervical motion tenderness absent (unlike PID) [3]
- Vulvar/perineal inspection: Visible varicosities in the vulva, labia, perineum, or buttocks [6]
- Lower extremity exam: Atypical varicose veins (medial thigh, posterior thigh, gluteal) that may refill after standing from supine position
- Musculoskeletal: Assess for myofascial trigger points, pelvic floor dysfunction
11. Lab Studies
- Recommended labs: Primarily to exclude other diagnoses
- Pregnancy test (urine β-hCG)
- Urinalysis and urine culture (rule out UTI; sterile hematuria may support PCS/nutcracker syndrome) [5]
- STI screening (gonorrhea/chlamydia NAAT) if PID suspected
- CBC, ESR/CRP if infection or inflammatory process suspected
- CA-125 if ovarian pathology or endometriosis suspected
- No specific lab marker for PCS exists
- Monitoring: If GnRH agonist therapy is used, monitor bone density and estrogen levels
12. Imaging
- First-line: Transvaginal duplex Doppler ultrasound (TVUS) [1][6][14]
- Key diagnostic criteria:
- Ovarian vein diameter >5–6 mm (some use >7–8 mm for higher specificity) [1][14-15]
- Low flow velocity ≤3 cm/s [1][15]
- Ovarian vein flow reversal [14]
- Tortuous pelvic/parauterine veins [14]
- Myometrial vein dilation >5 mm [1]
- Change of flow with Valsalva maneuver [15]
- TVUS confirmed PCS findings in 95.9% of cases subsequently verified by venography [16]
- Gold standard: Selective retrograde venography — reserved for patients in whom intervention is planned [6-7]
- CT venography or MR venography: Useful for identifying structural causes (nutcracker, May-Thurner) and pretreatment planning [6-7]
- Laparoscopy has limited sensitivity for PCS due to CO₂ pneumoperitoneum compressing veins and Trendelenburg positioning [1]
13. Special Tests
- Ultrasound-based scoring systems: Integrating diameter, reflux duration, velocity, Valsalva-evoked flow, bilaterality, and myometrial plexus enlargement — AUC 0.861 for predicting venography-confirmed PCS [15]
- Ovarian point tenderness + postcoital ache: 94% sensitivity, 77% specificity for venous-origin pelvic pain [3]
- Symptoms-Varices-Pathophysiology (SVP) classification: Standardized classification system from the American Vein & Lymphatic Society for categorizing pelvic venous disorders [3]
14. ECG
- Not routinely indicated for PCS
- Consider ECG only if chest pain, syncope, or hemodynamic instability is present (to rule out other causes)
- No specific ECG findings associated with PCS
15. Assessment
PCS is a clinical-radiologic diagnosis requiring correlation of characteristic symptoms (chronic dull pelvic pain worsened by standing, postcoital ache, premenstrual exacerbation) with imaging evidence of pelvic venous incompetence. [1][3][7] It remains a diagnosis of exclusion in many settings, as ACOG notes that evidence is insufficient to establish a definitive cause-and-effect relationship between venous congestion and pain. [11] However, a case-control study found PVI in 62% of women with CPP vs. 19% of controls (OR 6.79). [17]
Severity stratification
- Mild: Intermittent pain, manageable with conservative measures
- Moderate: Daily pain affecting function, visible varicosities
- Severe: Debilitating pain, failed medical therapy, significant QoL impairment
Underlying etiology must be classified: [8]
- Primary venous reflux (incompetent gonadal vein valves)
- Secondary venous obstruction (nutcracker syndrome, May-Thurner syndrome)
- Treatment differs based on etiology [7]
16. Treatment Plan
Initial/Conservative
- NSAIDs for pain relief
- Venoactive drugs: MPFF 1000 mg daily (demonstrated QoL improvement vs. placebo) [10]
- Hormonal suppression: MPA 30 mg/day or GnRH agonist (goserelin 3.6 mg/month × 6 months) for short-term relief [6][9]
Definitive/Interventional (mainstay of treatment)
- Percutaneous transcatheter embolization of refluxing ovarian and internal iliac vein tributaries with coils, plugs, and/or sclerotherapy [6]
- Technical success: 96–100% [4]
- Symptomatic relief in ~75% of women, increasing over time [18]
- Low complication rate (<2% coil migration risk) [18]
- VAS pain scores significantly reduced (e.g., from 8.5 to 2.4 at 90 days in one series) [19]
- For secondary obstruction (May-Thurner/nutcracker): Treat the obstruction first (iliac vein stenting or renal vein angioplasty) before considering gonadal vein embolization [7][13]
Surgical (if less invasive treatment fails)
- Ovarian vein ligation and excision [6]
- Hysterectomy with bilateral oophorectomy — last resort [6]
Reproductive considerations: Embolization may cause a modest decline in AMH levels, generally consistent with age-related changes, but effects in women <30 should be discussed [20]
17. Disposition
- Outpatient management is appropriate for the vast majority of PCS patients
- Admission criteria: Rarely needed; consider if acute complication (e.g., DVT, post-procedural complication) or severe uncontrolled pain
- Specialist consultation triggers:
- Interventional radiology — for embolization planning when diagnosis is confirmed and conservative therapy fails [6][21]
- Gynecology — for initial workup, exclusion of other CPP causes, hormonal management [1]
- Vascular surgery — if structural venous obstruction (May-Thurner, nutcracker) is identified [8]
- Pain management — for refractory cases or multimodal pain strategies
18. Follow Up / Return Precautions
- Post-embolization: Follow-up at 30 and 90 days to assess symptom improvement; subsequent imaging (Doppler US) to confirm occlusion [19][22]
- Medical therapy: Reassess at 8–12 weeks for symptom response; if inadequate, escalate to interventional referral
- Return precautions (patient counseling):
- Seek immediate care for acute severe pelvic pain, fever, leg swelling, or signs of DVT
- Post-embolization: transient pelvic pain is common (especially with foam sclerotherapy); persistent or worsening pain warrants re-evaluation [18]
- Expected course: PCS is a chronic condition; embolization provides sustained relief in the majority, but recurrence is possible and may require repeat intervention [4][18]
- Long-term: Periodic reassessment of symptoms and QoL; address comorbid anxiety/depression [9]
The following figure outlines a general approach to evaluating chronic pelvic pain, which is the typical presenting complaint in PCS:
References
1. Pelvic Congestion Syndrome: The Gynecological Perspective. — Krambeck C, Tesch K, Watrowski R, Maass N, Alkatout I. Journal of Clinical Medicine. 2026.
2. Comprehensive Overview of the Venous Disorder Known as Pelvic Congestion Syndrome. — Bałabuszek K, Toborek M, Pietura R. Annals of Medicine. 2022.
3. The Symptoms-Varices-Pathophysiology Classification of Pelvic Venous Disorders: A Report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders. — Meissner MH, Khilnani NM, Labropoulos N, et al. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2021.
4. Pelvic Venous Congestion Syndrome: Female Venous Congestive Syndromes and Endovascular Treatment Options. — Kashef E, Evans E, Patel N, Agrawal D, Hemingway AP. CVIR Endovascular. 2023.
5. A Forgotten Disease: Pelvic Congestion Syndrome as a Cause of Chronic Lower Abdominal Pain. — Jurga-Karwacka A, Karwacki GM, Schoetzau A, et al. PloS One. 2019.
6. The Care of Patients With Varicose Veins and Associated Chronic Venous Diseases: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. — Gloviczki P, Comerota AJ, Dalsing MC, et al. Journal of Vascular Surgery. 2011.
7. Imaging Appearance and Nonsurgical Management of Pelvic Venous Congestion Syndrome. — Bookwalter CA, VanBuren WM, Neisen MJ, Bjarnason H. Radiographics : A Review Publication of the Radiological Society of North America, Inc. 2019.
8. Symptomatic Pelvic Venous Insufficiency: A Review of the Current Controversies in Pathophysiology, Diagnosis, and Management. — Barge TF, Uberoi R. Clinical Radiology. 2022.
9. A Randomized Controlled Trial of Goserelin and Medroxyprogesterone Acetate in the Treatment of Pelvic Congestion. — Soysal ME, Soysal S, Vicdan K, Ozer S. Human Reproduction. 2001.
10. Clinical Efficacy of Conservative Treatment With Micronized Purified Flavonoid Fraction in Female Patients With Pelvic Congestion Syndrome. — Akhmetzianov RV, Bredikhin RA. Pain and Therapy. 2021.
11. Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218. — Committee on Practice Bulletins—Gynecology Obstetrics and Gynecology. 2020.
12. Chronic Pelvic Pain in Women: A Review. — Lamvu G, Carrillo J, Ouyang C, Rapkin A. The Journal of the American Medical Association. 2021.
13. Pelvic Congestion Syndrome Due to Central Venous Outflow Obstruction: A Single-Center Experience With May-Thurner and Nutcracker Syndromes. — Wu WC, Hsu WH, Chang TC, Huang LW. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics. 2025.
14. ACR Appropriateness Criteria® Postmenopausal Subacute or Chronic Pelvic Pain: Update 2025. — Expert Panel on GYN and OB Imaging, Shampain KL, Feldman MK, et al. Journal of the American College of Radiology : JACR. 2026.
15. Optimizing Venographic Referrals in Pelvic Congestion Syndrome: A Prospective Diagnostic Accuracy Study of Ultrasound-Based Scoring to Guide Selective Venography. — Mansouri-Tehrani MM, Shahnazari R, Iraji H, Mansouri Tehrani MM, Ghasemi M. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 2026.
16. The Usefulness of Transvaginal Ultrasonography in the Diagnosis of Pelvic Venous Disorders. — Szkodziak F, Woźniak S, Kudła M, et al. Scientific Reports. 2025.
17. Pelvic Vein Incompetence and Chronic Pelvic Pain: A Case-Control Study. — Hansrani V, Riding D, Seif MW, et al. BJOG : An International Journal of Obstetrics and Gynaecology. 2023.
18. Effectiveness of Embolization or Sclerotherapy of Pelvic Veins for Reducing Chronic Pelvic Pain: A Systematic Review. — Daniels JP, Champaneria R, Shah L, et al. Journal of Vascular and Interventional Radiology : JVIR. 2016.
19. Endovascular Treatment of Pelvic Venous Congestion Syndrome in Nulliparous Patients-Preliminary Results of 10 Years of Experience. — Szmygin M, Pyra K, Bèrczi V, et al. Cardiovascular and Interventional Radiology. 2024.
20. Efficacy of Endovenous Embolization for Pelvic Congestion Syndrome and Its Impact on Ovarian Reserve. — Karakaya HC, Dirican Ozen B, Eskin P, et al. Reproductive Biology and Endocrinology : RB&E. 2025.
21. Diagnosis and Management of Pelvic Venous Disorders: Expert Panel Narrative Review. — Knuttinen MG, Machan L, Khilnani NM, et al. AJR. American Journal of Roentgenology. 2023.
22. Endovascular Management of Pelvic Congestion Syndrome: An Expert Consensus Statement From the French Society of Cardiovascular Imaging (SFICV), Interventional Radiology Federation (FRI), College of French Radiology Teachers (CERF), and French Society of Women's Imaging (SIFEM). — Pennec VL, Douane F, Brun JL, et al. Diagnostic and Interventional Imaging. 2025.
23. Chronic Pelvic Pain in Women: Evaluation and Treatment. — Meisenheimer ES, Carnevale AM. American Family Physician. 2025.